Oncolin is currently engaged in the business of indentifying,
evaluating, developing and acquiring potential natural gas and oil
wells while researching new methods of clean and renewable energy
production. The company will initially focus on acquiring older fields
where it can utilize modern techniques to re-establish or enhance
production. Oncolin will continue to oversee its minority ownership in
Intertech Bio, a biopharmaceutical company that engages in the
discovery, development and commercialization of novel selective
anticancer therapies.